Women and HIV/AIDS - Research and Clinical Trials
Links shared publicly online about this topic.
- 3,526total visits
Women and HIV/AIDS - Research and Clinical Trials
View full resource at womenshealth.gov
Tags: Vaccination, HIV, AIDS, STD, Clinical Trial, Women's Health, Vaccine
Most Recently Shared on May 18, 2010 at 4:55 pm By:
RT @womenshealth: The effort to develop a vaccine for #HIV continues. It is HIV Vaccine Awareness Day. http://bit.ly/93guef
AIDSmeds - Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in HIV Studies - by Tim Horn
aidsmeds.com — “Genetically modified T cells--notably CD4 and CD8 cells--administered to people living with HIV participating in one of three clinical trials conducted between 1998 and 2002 are detectable more than a decade later, suggesting that single infusions of cells altered to target or block HIV have the potential for long-term efficacy. According to the paper, published in the May 2 issue of Science Translational Medicine and summarized in a University of Pennsylvania news release, the long-term safety ” View full resource at aidsmeds.com
Most Recently Shared on May 4, 2012 at 12:54 pm By:
Top Stories : Gene-Modified T Cells Persist for a Decade, Without Major Risks, in #HIV Studies http://t.co/CxlMuGLC #AIDS
AIDSmeds - Top Stories : Hormonal Contraception Not Linked to HIV Risk
aidsmeds.com — “A new analysis of data from a clinical trial conducted by the HIV Prevention Trials Network (HPTN) casts doubt on a study reported last summer suggesting that women using hormonal contraception are at greater risk of acquiring HIV.” View full resource at aidsmeds.com
Most Recently Shared on April 24, 2012 at 1:05 pm By:
Top Stories : Hormonal Contraception Not Linked to #HIV Risk http://t.co/wQrBTJJV #AIDS
AIDSmeds - Top Stories : HIV Vaccine Study Offers Up Possible Antibody Protection Clues
aidsmeds.com — “Scientists continued to unravel clues as to why a combination of two preventive HIV vaccines, ALVAC HIV and AIDSVAX B/E, may have worked for some but not others in a large scale clinical trial reported in 2009.” View full resource at aidsmeds.com
Most Recently Shared on April 11, 2012 at 4:47 pm By:
Until There's A Cure Health Organization
#HIV Vaccine Study Offers Up Possible Antibody Protection Clues http://t.co/sn2eWy1q @pozmagazine Join the Conversation
HIV-AIDS Trials: Black Women Often Left Out
theroot.com — “African-American women are routinely left out of clinical studies that could lead to new treatments.” View full resource at theroot.com
Most Recently Shared on April 6, 2012 at 3:20 pm By:
Health Literacy Medical School
HIV #AIDS Clinical Studies - No Place for Black ♀ http://t.co/LT5cH0bu @TheRoot247
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer
medicalnewstoday.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantl” View full resource at medicalnewstoday.com
Most Recently Shared on March 27, 2012 at 7:05 am By:
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer: Results ... http://t.co/UZsEDAbO
Treatment with aromatase inhibitors enables some women to have lumpectomy
news-medical.net — “Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 4:57 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Treatment with aromatase inhibitors enables some women to have lumpectomy: Preoperative treatment... http://t.co/muxRjZcl
Combination of everolimus and exemestane reduces spread of cancer in the bone
news-medical.net — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 3:48 pm By:
Combination of everolimus and exemestane reduces spread of cancer in the bone: Results from a phase III clinical... http://t.co/U7ANfKPL
New therapy may help ovarian cancer patients | News.com.au
news.com.au — “AN Australian drug developer will in coming months begin recruiting 120 women with ovarian cancer for a clinical trial of a new therapy.” View full resource at news.com.au
Most Recently Shared on March 23, 2012 at 2:16 pm By:
New hope for ovarian cancer patients: AN Australian drug developer will soon begin recruiting 120 women with ova... http://t.co/aFgxgQva
Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy
medicalxpress.com — “Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society ...” View full resource at medicalxpress.com
Most Recently Shared on March 23, 2012 at 1:19 pm By:
PhysOrg Health News Health News
Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy http://t.co/C2LeTXUz
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer
medicalxpress.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.” View full resource at medicalxpress.com
Most Recently Shared on March 23, 2012 at 1:16 pm By:
PhysOrg Health News Health News
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer http://t.co/iI46fpTu
BMC Clinical Pharmacology | Abstract | Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial
biomedcentral.com — “Consistent with its effect on gastric emptying, exenatide, an injectable treatment for type 2 diabetes, may slow the absorption rate of concomitantly administered oral drugs resulting in a decrease in maximum concentration (Cmax). This study evaluated the drug interaction potential of exenatide when administered adjunctively with oral contraceptives, given their potential concomitant use.” View full resource at biomedcentral.com
Most Recently Shared on March 20, 2012 at 9:35 pm By:
Effect of exenatide on the pharmacokinetics of a combination oral contraceptive http://t.co/NtAJ9ZIb
FDA approves new silicone gel-filled breast implant
fda.gov — “Today, the U.S. Food and Drug Administration approved a silicone gel-filled breast implant manufactured by Sientra Inc. to increase breast size (augmentation) in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. As a condition of approval, Sientra is required to conduct post-approval studies that will assess long-term safety and effectiveness outcomes as well as the risks of rare disease outcomes.” View full resource at fda.gov
Most Recently Shared on March 9, 2012 at 7:33 pm By:
eyeonfda Pharma and Health Lawyer
#FDA approves new silicone gel-filled breast implant http://t.co/z2fCoyIf
New clinical trial: Pycnogenol improves signs and symptoms of menopause
news-medical.net — “Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative or natural remedies are an easy, effective way to improve signs and symptoms linked to the menopausal transition, without side effects.” View full resource at news-medical.net
Most Recently Shared on March 7, 2012 at 2:22 pm By:
New clinical trial: Pycnogenol improves signs and symptoms of menopause: Half the population experiences menopau... http://t.co/FXGuai1l
Pycnogenol® (French Maritime Pine Bark Extract) Shown to Improve Menopause Signs and Symptoms in New Clinical Trial - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: HOBOKEN, N.J., March 7, 2012 /PRNewswire/ -- Half the population experiences menopause, and for those women, it is a condition they will experience for approximately one third of their lifetime. Alternative ...” View full resource at finance.yahoo.com
Most Recently Shared on March 7, 2012 at 2:22 pm By:
Pycnogenol® (French Maritime Pine Bark Extract) Shown to Improve Menopause Signs and Symptoms in New Clinical Tr... http://t.co/TfFRVSsS
AIDSmeds - Top Stories : HIV Therapeutic Vaccine Developer Reports Encouraging Results
aidsmeds.com — “Vacc-4x, an experimental therapeutic HIV vaccine, helps reduce viral load among people living with HIV remaining off antiretroviral (ARV) therapy for six months, compared with those who didn?t receive the vaccine, according to preliminary results from a clinical trial highlighted in a news announcement by the compound?s developer Bionor Pharma.” View full resource at aidsmeds.com
Most Recently Shared on February 27, 2012 at 2:15 pm By:
Top Stories : HIV Therapeutic Vaccine Developer Reports Encouraging Results http://t.co/lDA0gCmI #HIV #AIDS
Advertisement
